Essam Aljindy

Essam Aljindy serves as Deputy Chief Technical Officer at SVAX. SVAX operates in the pharmaceuticals sector with approximately 22.0 employees. The company is headquartered in Eastern Province.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 63 executive contacts are available in Eastern Province.
• • Our database includes 201,469 c suite-level executives.

Gmail Google Apps Amazon AWS Mobile Friendly Remote AI

biopharmaceutical pharmaceutical biotechnology biomanufacturing cdmo pharmaceutical manufacturing halal vaccines biopharmaceuticals vaccines manufacturing drug discovery localization of biomanufacturing pandemic preparedness health security clinical evaluation biologic manufacturing diagnostic kits biopharmaceutical analytics quality testing research & development gmp manufacturing cell & gene therapies immunization programs infectious diseases biotechnology ecosystem technology transfer vaccine development therapeutics production vaccines shortfalls biologics manufacturing affordable healthcare research agreements collaborative training licensed vaccines finished dosage formulations active biological ingredients quality control bioprocessing upstream processing downstream processing aseptic processing fill & finish stability testing vaccine pipeline community health r&d facilities saudi vision 2030 socio-economic development public health women in biotechnology biomanufacturing training innovation in healthcare medical supply chain medical pharmaceuticals health wellness & fitness

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Essam Aljindy in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at SVAX.

Essam Aljindy's Position in the MessageCEO Database

• •Essam Aljindy is 1 of 1 verified executive contact we track at SVAX.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •63 verified executive contacts in Eastern Province are in the database.
• •11 verified contacts work at pharmaceuticals companies in the 22.0 employee range (same size as SVAX).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Essam Aljindy directly?

Essam Aljindy's verified email address is available to MessageCEO Pro subscribers. They currently serve as Deputy Chief Technical Officer at SVAX. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Essam Aljindy work for?

Essam Aljindy is Deputy Chief Technical Officer at SVAX, a company in the pharmaceuticals sector with 22.0 employees. The company is based in Eastern Province.

Can I pitch or sell to Essam Aljindy?

As Deputy Chief Technical Officer at SVAX, Essam Aljindy is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Essam Aljindy directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Essam Aljindy in?

Essam Aljindy works in the pharmaceuticals industry as Deputy Chief Technical Officer at SVAX. MessageCEO provides verified contact information for executives across all major industries.

Is Essam Aljindy's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Essam Aljindy's profile is kept up-to-date with the latest available information.

Last updated: June 22, 2026